Covance in Madison has started the first human trial of the first vaccine designed specifically for leprosy, an ancient disease that continues to sicken about a quarter of a million people worldwide each year.
DAVID WAHLBERG dwahlberg@madison.com, Wisconsin State Journal
Thu, 10/12/2017 - 2:05pm
Covance in Madison has started the first human trial of the first vaccine designed specifically for leprosy, an ancient disease that continues to sicken about a quarter of a million people worldwide each year.